Kuros Biosciences USA, Inc., a wholly owned subsidiary of Kuros Biosciences AG, has entered into a five-year, exclusive sales agency agreement with the Medtronic spinal division.
Kuros is a biopharmaceutical company that develops and commercializes implantable technologies which support musculoskeletal bone healing.
Subscribe to continue reading
- Unlimited access to our content and archive
- Exclusive access to our newsletter
- Join the Conversation! Exclusive access to article comments.
